Significantly, analysis of the TCGA dataset revealed that MTBP is amplified in 19% breast cancer, and its mRNA expression levels are notably elevated in TNBC relative to those in other subtypes of breast cancer.28 This evidence concerns the gene MTBP and breast carcinoma.